Total Funding
78
71
Total FundingPost-IPO Debt raised
Growth Score
-10 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23187
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products
Rawan Musleh: RIMS Specialist- Said Darwazah: CEOPast Role: Hikma Pharmaceuticals, Chief Executive Officer
About the Company
Hikma was founded in 1978 in Amman, Jordan by Samih Darwazah, our current Chairman and CEO. In the early years, the Company’s primary focus was on developing a branded pharmaceuticals business across the MENA Region. Then in the early 1990’s, Hikma expanded outside the MENA Region by acquiring a generic pharmaceuticals business in the United States
and by establishing injectable pharmaceutical operations in Portugal. Since then, the company has expanded significantly, both organically and through acquisition.
